Influence of formulation additives on the vapor pressure of hydrofluoroalkane propellants

International Journal of Pharmaceutics

Volumn 166, Issue 1, 1998, Pages 99-103

  Williams III, Robert O ^a   Liu, Jie ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

HFA 134a; HFA 227; Vapor pressure

Indexed keywords

ALCOHOL; APAFLURANE; FLUORINATED HYDROCARBON; MICROCRYSTALLINE CELLULOSE; NORFLURANE; PROPELLANT; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; ENTHALPY; METERED DOSE INHALER; PRESSURE; PRIORITY JOURNAL; TEMPERATURE; VAPOR; VAPORIZATION;

EID: 0032507735     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00031-3     Document Type: Article

References (12)

1. Atkins, P.W., 1982. Physical Chemistry, 2nd ed., W.H. Freeman, San Francisco.
2. Dalby, R.N., Hickey, A.J., Tiano, S.L., 1996. Medical devices for the delivery of therapeutic aerosols to the lungs. In: Hickey, A.J. (Ed.), Inhalation Aerosols: Physical and Biological Basis for Therapy. Marcel Dekker, New York, pp. 441-473.
3. Byron, P., Blondino, F., 1996a. Metered dose inhaler formulations which included the ozone-friendly propellant HFC 134A and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent. US Patent 5,492,688, Feb. 1996.
4. Byron, P., Blondino, F., 1996b. Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant. US Patent 5,508,023, Apr. 1996.
5. Gonda, I., 1992. Targeting by deposition. In: Hickey, A.J. (Ed.), Pharmaceutical Inhalation Aerosol Technology, Marcel Dekker, New York, pp. 155-185.
6. Harnor K.J., Perkins A.C., Wastie M., Wilson C.G., Sims E.E., Feely L.C., Farr S.J. Effect of vapor pressure on the deposition pattern from solution phase metered dose inhalers. Int. J. Pharm. 95:1993;111-116.
7. June D.S., Schultz R.K., Miller N.C. A conceptual model for the development of pressurized metered-dose hydrofluoroalkane-based inhalation aerosols. Pharm. Technol. 18:1994;40-52.
8. Lostritto R.T. A non-empirical model describing the phase behavior of propellant vehicles. Pharm. Res. 13(suppl.):1996;177.
9. Martin, A., 1993. Physical Pharmacy, 4th ed., Lea&Febiger, Philadelphia.
10. Newman S.P., Morén F., Pavia D., Corrado O., Clarke S.W. The effects of changes in metered volume and propellant vapour pressure on the deposition of pressurized inhalation aerosols. Int. J. Pharm. 11:1982;337-344.
11. Rance R.W. Studies of the factors controlling the action of hair sprays. III. The influence of particle velocity and diameter on the capture of particles by arrays of hair fibres. J. Soc. Cosmet. Chem. 25:1974;545-561.
12. Wade, A., Weller, P.J., (Eds.), 1994. Handbook of Pharmaceutical Excipients, 2nd ed., American Pharmaceutical Association, Washington, DC.